Investor Alert: Robbins LLP Informs Investors of the Corcept Therapeutics Inc. Class Action Lawsuit

Core Viewpoint - A class action lawsuit has been filed on behalf of investors who purchased Corcept Therapeutics common stock between October 31, 2024, and December 30, 2025, indicating potential legal challenges for the company [1]. Company Overview - Corcept Therapeutics is a pharmaceutical company focused on developing medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol [1].